Navigation Links
Patient Safety in Challenging Economic Times is Focus of NPSF Annual Congress on May 20-22
Date:1/13/2009

collaborate with safety experts and influential healthcare leaders.

"Now more than ever, an unwavering focus on patient safety is critical," noted Ms. Pinakiewicz. "The risks are too great to respond otherwise."

Visit http://www.npsf.org for complete program details and registration information. Attendees may also register by calling 401.766.4904.

About the National Patient Safety Foundation

The National Patient Safety Foundation is an independent not-for-profit 501(c)(3) organization that has been diligently pursuing one mission since its founding in 1997 -- to improve the safety of patients. NPSF also occupies a unique position by virtue of its inclusive, multi-stakeholder approach, which fosters collaboration on the issue of patient safety.


'/>"/>
SOURCE National Patient Safety Foundation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
5. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
6. Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients
7. Cardinal Health Establishes $1 Million Grant Fund for Initiatives That Improve Quality, Safety of Patient Care
8. New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome
9. Stimuvax(R) Phase II data highlight three-year survival results for patients with non-small cell lung cancer
10. Spectrum Pharmaceuticals Initiates Second Registrational Phase 3 Clinical Trial for EOquin(R) in Patients With Non-Invasive Bladder Cancer
11. Ortho Biotech Supports FDA Advisory Committees Recommendations on Use of ESAs in Chronic Renal Failure Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... , Aug. 22, 2014 Research ... "Global and China Gel Permeation Chromatography (GPC) Industry ... The Global and China Gel Permeation Chromatography (GPC) ... the current state of the global gel permeation chromatography ... The report provides a basic overview of the industry ...
(Date:8/22/2014)... Angeles (PRWEB) August 22, 2014 ... age-defying products, is in the spotlight again. Nerium ... cream and its NeriumFirmTM Body Contouring Cream to ... by Backstage Creations during the 66th Primetime Emmy® ... patented NAE-8® extract, third-party clinical trials show that ...
(Date:8/21/2014)... , Aug. 21, 2014  BioSpecifics Technologies ... company developing first in class collagenase-based products marketed ... CCH) in the U.S. and XIAPEX ® ... results from a randomized, double-blind Phase 2a study ... or edematous fibrosclerotic panniculopathy. The results showed that ...
(Date:8/21/2014)... including DESY scientists has observed tiny quantum vortices in ... the journal Science that the exotic vortices ... It is the first time that the quantum vortices, ... what is known as superfluid helium, have been detected ... says Andrey Vilesov of the University of Southern California, ...
Breaking Biology Technology:Global and China Gel Permeation Chromatography (GPC) Industry Report 2014 2Nerium International Joins Television’s Biggest Stars at Backstage Creations Giving Suite at the 66th Primetime Emmy Awards 2Nerium International Joins Television’s Biggest Stars at Backstage Creations Giving Suite at the 66th Primetime Emmy Awards 3BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 2BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 3BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 4BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 5Scientists observe quantum vortices in cold helium droplets 2
... Jan. 14 Shamir,Optical Industry Ltd. (Nasdaq: ... and technology to the progressive ophthalmic lens,market, announced ... a dividend,distribution in an aggregate amount of US$ ... January 11, 2008 representative rate of,exchange), or approximately ...
... HAIKOU, China, Jan. 14 /Xinhua-PRNewswire-FirstCall/ --,China Pharma ... CPHI),which develops, manufactures, and markets generic and ... it has retained,HC International, Inc. (HCI) to ... Matthew Hayden and Alan Sheinwald of HCI, ...
... Today, The Woodbridge Group announced,the most ... highest,levels of "Green" Polyurethane Foams. As a ... a patented technology, substitutes petroleum,with plant oils, ... solution for a full line-up of automotive ...
Cached Biology Technology:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3China Pharma Holdings, Inc. Retains HC International, Inc. to Implement Investor Relations Program 2China Pharma Holdings, Inc. Retains HC International, Inc. to Implement Investor Relations Program 3Woodbridge Offers the Broadest Range of BioFoam(TM) 'Green' Polyurethane Automotive Interior Applications 2
(Date:8/22/2014)... rhino reproduction in Europe highlights how hormone analysis ... Researchers from Chester Zoo, The University of Manchester ... six-year study which encompassed 90% of European population ... the research as part of her PhD at ... black rhinoceros breed well in captivity, not all ...
(Date:8/22/2014)... 3β-Hydroxysteroid-Δ24 reductase (DHCR24) is a multifunctional ... reticulum and has neuroprotective and cholesterol-synthesizing ... apoptosis caused by amyloid β deposition. ... Liaoning University in China constructed two ... drive DHCR24 expression specifically in neuronal ...
(Date:8/22/2014)... Stanford, CAEveryone,s heard of the birds and the ... flowers that are being fertilized. The fertilization process ... extensive communication between the male and female reproductive ... Stanford, Regensburg, Heidelberg, and Munich, and including Carnegie,s ... discoveries in the chemical signaling process that guides ...
Breaking Biology News(10 mins):Hormone analysis helps identify horny rhinos 2Calcium and reproduction go together 2
... is a better strategy, specializing in one crop ... than organic farming? Is it less risky? ... College of Agriculture and Life Sciences and Michael ... Cropping Systems Trial (WICST) in 1990. This research ...
... ANGELES Researchers from the University of Southern ... protecting against Huntington disease using gene therapy. ... by uncontrolled movements, emotional instability and loss of ... the United States, and children of parents with ...
... explain their ability to respond to regulatory inputs from ... of companion articles from the FANTOM4 consortium. This research, ... open access journals, including Genome Biology and ... (highly conserved non-coding element) mediated long-range gene regulation at ...
Cached Biology News:New hope for treatment of neurodegenerative disorder 2New hope for treatment of neurodegenerative disorder 3FANTOM findings boost for biologists 2
...
... Deacetylase (HDAC) Antibody Sampler Kit Kit ... Catalog #2062, 40 ul Histone Deacetylase 3 ... Deacetylase 4 (HDAC4) Antibody, Catalog #2072, 40 ... #2082, 40 ul Histone Deacetylase 6 (HDAC6) ...
Recombinant Mouse Matrilin-4, CF Protein Family: Extracellular Matrix Molecules, Chondrogenesis Markers...
Immunogen: Synthetic Peptide: C N(185) D G T E F G G S I Y Q K(197) Storage: -20 C, Avoid Freeze/Thaw Cycles...
Biology Products: